BridgeMD
New treatment option for Intimate Partner Violence (IPV)
Official title Multi-component Family Intervention to Lower Depression and Address Intimate Partner Violence in Nepal
ClinicalTrials.gov ID: NCT06834867
What this study is testing
- What it's testing
- Intimate Partner Violence (IPV) is a major public health problem in low- and middle-income countries (LMICs). Globally, an estimated 30% of women report physical or sexual violence by an intimate partner in their lifetime.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 24
You may be able to join if
- Married women aged 15-24 years, their husbands and MILs sharing a household;
- Living in the catchment area with no stated intention of leaving during the study period;
- Participants speaking in Maithili or Nepali;
- Wife reporting Intimate Partner Violence (physical, sexual or abusive control) in last 12 months as measured by three questions from the...
- Expressing desire to remain in the current relationship/family
You likely can't join if
- Pregnant women;
- History of IPV severe enough to result in hospitalization in the past 12 months;
- Significant cognitive problems/disability precluding participation;
- Any participant with Severe Alcohol Dependence, defined as Severity of Alcohol Dependence Questionnaire (SADQ) \> 31 (those with mild to moderate...
The study team makes the final eligibility decision.
Where it's taking place
- Kathmandu, Bagmati, Nepal
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 15 years to 24 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kathmandu, Bagmati, Nepal. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.